TABLE 5.

Hematology parameter values of hyperlipidemic volunteers at baseline, day 30, and day 60 during phase 2 (mean ± SD).

	Control (n = 25)	250 mg OPP (n = 25)
ESR (mm/hr)
Day 1	15.96 ± 12.21	14.52 ± 9.92
Day 30	12.96 ± 12.40	12.52 ± 9.19
Day 60	14.20 ± 11.57	14.80 ± 11.46
RBCs (1012/L)
Day 1	4.92 ± 0.58	4.80 ± 0.45
Day 30	4.94 ± 0.54	4.89 ± 0.51a
Day 60	4.91 ± 0.52	4.92 ± 0.45a
Hb (g/dL)
Day 1	13.78 ± 1.55	13.64 ± 1.34
Day 30	13.76 ± 1.56	13.82 ± 1.52
Day 60	13.68 ± 1.54	13.84 ± 1.32
PCV (%)
Day 1	40.64 ± 4.17	40.80 ± 3.62
Day 30	40.76 ± 4.14	41.60 ± 4.08a
Day 60	40.68 ± 4.27	41.64 ± 3.62a
MCV (fL)
Day 1	83.28 ± 5.95	85.04 ± 4.84
Day 30	83.00 ± 5.93	85.04 ± 4.76
Day 60	83.36 ± 6.36	85.00 ± 4.86
MCH (pg)
Day 1	28.40 ± 2.45	28.40 ± 1.94
Day 30	28.04 ± 2.39	28.28 ± 1.86
Day 60	27.96 ± 2.37a	28.24 ± 1.92
MCHC (109/L)
Day 1	33.92 ± 1.38	33.28 ± 0.68
Day 30	33.72 ± 1.06	33.32 ± 0.90
Day 60	33.64 ± 1.19	33.32 ± 0.75
Platelet (109/L)
Day 1	308.12 ± 96.03	285.28 ± 53.29
Day 30	313.36 ± 94.05	295.92 ± 51.94
Day 60	306.72 ± 82.53	292.84 ± 56.86
WBCs (109/L)
Day 1	7.46 ± 2.15	6.50 ± 1.44
Day 30	7.37 ± 1.38	6.38 ± 1.33*
Day 60	7.29 ± 1.36	6.50 ± 1.63
Neutrophil (%)
Day 1	56.15 ± 8.87	52.87 ± 8.18
Day 30	56.00 ± 5.86	52.49 ± 7.94
Day 60	57.20 ± 9.36	52.07 ± 8.61
Lymphocytes (%)
Day 1	34.18 ± 7.84	37.00 ± 7.42
Day 30	34.28 ± 5.22	37.17 ± 7.01
Day 60	33.58 ± 8.42	37.20 ± 7.30
Monocytes (%)
Day 1	5.94 ± 1.57	6.51 ± 1.48
Day 30	6.32 ± 1.56	6.54 ± 1.55
Day 60	6.13 ± 1.45	6.78 ± 1.42
Eosinophils (%)
Day 1	3.17 ± 2.93	3.01 ± 1.94
Day 30	2.84 ± 1.64	3.17 ± 2.03
Day 60	2.54 ± 1.39	3.30 ± 2.48
Basophil (%)
Day 1	0.56 ± 0.24	0.61 ± 0.20
Day 30	0.56 ± 0.16	0.64 ± 0.31
Day 60	0.55 ± 0.20	0.64 ± 0.27

^aSignificantly different compared to day 1 within the group (p < 0.05).

^bSignificantly different compared to day 1 within the group (p < 0.001).

*Significantly different compared to control group (p < 0.05).